Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2012
04/11/2012CN102406567A 一种茴香消炎牙膏 One kind of inflammatory fennel toothpaste
04/11/2012CN102406557A 一种肉豆蔻护齿牙膏 One kind of toothpaste nutmeg mouthguard
04/11/2012CN102406544A Azithromycin lactobionateinjection solution packaged by double-cavity bag and preparation method
04/11/2012CN102406543A Ceftazidime injection solution packaged by double-cavity bag and preparation method thereof
04/11/2012CN102405935A 鱼精蛋白复配制剂及其制备方法和应用 Protamine complex and its preparation method and application
04/11/2012CN102085219B 一种治疗传染性腮腺炎膏药及其制备方法 A contagious plaster and preparation method for the treatment of mumps
04/11/2012CN101987129B 一种治疗骨髓炎的中药制剂 A method of treating osteomyelitis of Chinese medicine
04/11/2012CN101940730B 一种治疗流行性急性传染病的中药 A traditional Chinese medicine treatment of acute infectious disease epidemic
04/11/2012CN101816791B 一种含头孢美唑和β-内酰胺酶抑制剂的药物组合物 Containing cefmetazole and β- lactamase inhibitor pharmaceutical composition
04/11/2012CN101618039B 肺炎的治疗药物 Pneumonia therapy
04/11/2012CN101454014B 用于治疗或预防白斑综合症病毒的组合物和方法 The compositions and methods for treating or preventing WSSV for
04/11/2012CN101448504B 吉西他滨酰胺前体药物的结晶形式、其组合物以及用途 Gemcitabine coast crystalline form amide prodrugs, compositions and uses thereof
04/11/2012CN101390994B 一种治疗带状疱疹的药物 A method of treating herpes zoster drug
04/11/2012CN101309932B 新粘蛋白型糖蛋白及其应用 New mucin-type glycoprotein and its applications
04/11/2012CN101306085B 一种治疗水疱型手足癣的外搽药物 A method of treating tinea of ​​vesicular drug Waicha
04/11/2012CN101301416B 一种治疗百日咳的汤剂药物 A method of treating drug decoction of whooping cough
04/11/2012CN101199659B 一种治疗急性结膜炎的内服中药 A method of treating acute conjunctivitis internal medicine
04/10/2012US8153806 Synthesis of 4-amino-thalidomide enantiomers
04/10/2012US8153796 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof
04/10/2012US8153787 Azacytosine derivatives useful as antiviral agents
04/10/2012US8153776 Using targeted gene expression inhibition to treat and prevent viral infection
04/10/2012US8153652 Fab I inhibitors
04/10/2012US8153640 Reverse transcriptase inhibitors; use against HIV with drug resistance to NNRTI's (Non Nucleoside Reverse Transcriptase Inhibitor drugs); Diaryl Pyrrolo(2,3-d)pyrimidines, diaryl purines, diaryl v-triazolo(4,5-d)pyrimidines
04/10/2012US8153625 Nitrogen-containing heterocyclic compounds and medicinal use thereof
04/10/2012US8153610 T cell clones; drug screening
04/10/2012US8153360 Flavivirus fusion inhibitors
04/10/2012US8153138 Recombinant MVA virus
04/10/2012US8153133 High potency recombinant antibodies and method for producing them
04/10/2012US8153124 Method for treating cancer using monoclonal antibodies
04/10/2012CA2676003C Compositions of stable tiacumicins
04/10/2012CA2571984C Antiviral compounds
04/10/2012CA2534349C Human skin equivalents expressing exogenous polypeptides
04/10/2012CA2491802C Novel compounds, pharmaceutical compositions containing same, and methods of use for same
04/10/2012CA2486663C Method of treating rosacea by topical application of a cyclohexane derivative
04/10/2012CA2486308C Hepatitis c virus inhibitors
04/10/2012CA2477857C Stabilized liquid polypeptide-containing pharmaceutical compositions
04/10/2012CA2473754C Treatment of ms with goat serum
04/10/2012CA2445408C Quinolone carboxylic acid compositions and related methods of treatment
04/10/2012CA2445253C Single chain camelid vhh antibodies, method for their production in a mammal, and their uses
04/10/2012CA2438921C Streptococcus pyogenes polypeptides and corresponding dna fragments
04/10/2012CA2401032C Memno peptides, a process for their preparation and their use
04/10/2012CA2395713C G-csf conjugates
04/10/2012CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof
04/10/2012CA2238843C Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
04/05/2012WO2012045083A2 Minimizing intestinal dysfunction
04/05/2012WO2012044531A1 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
04/05/2012WO2012044140A1 Anti-tuberculosis preparation in tablet form and process for preparing same
04/05/2012WO2012043949A1 Composition for enhancing immunity containing compounds represented by chemical formulas 1-8 or sophora flavescens extract as active ingredient
04/05/2012WO2012043838A1 Inhibitor for hepatitis c virus infection
04/05/2012WO2012043743A1 Anti-bacterial composition and use thereof
04/05/2012WO2012043700A1 Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
04/05/2012WO2012043696A1 Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
04/05/2012WO2012043651A1 Production method for myeloid blood cells
04/05/2012WO2012043052A1 Surgical cleaning solution
04/05/2012WO2012042857A1 Mucosal adjuvant composition
04/05/2012WO2012042482A1 Process for the synthesis of funicone analogues
04/05/2012WO2012041981A2 Use of growth hormone to enhance the immune response in immunosuppressed patients
04/05/2012WO2012041934A1 Polysubstituted 2-aminoimidazoles for controlling biofilms and process for their production
04/05/2012WO2012041771A1 Combination therapy for treating hcv infection
04/05/2012WO2012041493A1 Aminoquinolinium salts, methods of their production and their use as active agents for biotechnological and medical applications against binary toxins
04/05/2012WO2012041227A1 Tetracyclic heterocycle compounds for treating hepatitis c viral infection
04/05/2012WO2012041014A1 Tetracyclic indole derivatives for treating hepatitis c virus infection
04/05/2012WO2012040924A1 Fused tetracyclic heterocycle compounds and methods of use thereof for treatment of viral diseases
04/05/2012WO2012040923A1 Tetracyclic indole derivatives and methods of use thereof for the treatment of viral diseases
04/05/2012WO2012040841A1 Use of nigericin to treat and prevent vaccinia virus infections
04/05/2012WO2012017328A3 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
04/05/2012WO2012012498A9 Use of trp channel agonists to treat infections
04/05/2012WO2011140310A3 Povidone-iodine topical composition
04/05/2012WO2011139832A3 Method for treating mycobacterial infections
04/05/2012WO2011133929A3 Reducing transmission of sexually transmitted infections
04/05/2012WO2011133722A3 Anti-viral compounds
04/05/2012WO2011133719A3 Anti-viral compounds
04/05/2012WO2011032050A3 Gyrase inhibitors
04/05/2012US20120083536 Antimicrobial adhesive system
04/05/2012US20120083532 Novel uses
04/05/2012US20120083531 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
04/05/2012US20120083515 Bioadhesive gel based on hydroxyethylcellulose
04/05/2012US20120083512 Pharmaceutical product for injection
04/05/2012US20120083510 Perfluorocarbons for use in treating pruritus
04/05/2012US20120083498 Modulators of Viral Transcription, and Methods and Compositions Therewith
04/05/2012US20120083495 Compounds for the treatment of spinal muscular atrophy and other uses
04/05/2012US20120083492 Imidazopyrazines for use as kinase inhibitors
04/05/2012US20120083490 Cytochrome p450 oxidase inhibitors and uses thereof
04/05/2012US20120083469 Inhibitors of arginase and their therapeutic applications
04/05/2012US20120083462 Pharmaceutical anti-infective composition for inhalation
04/05/2012US20120083444 Emulsion Method For Preparing Low Residual Solvent Microparticles
04/05/2012US20120083441 Pharmaceutical Compositions
04/05/2012US20120083440 Methods and compounds for the targeted delivery of agents to bone for interaction therewith
04/05/2012US20120082742 Method and compositions for treating cutaneous verrucae
04/05/2012US20120082738 Mucosal formulation
04/05/2012US20120082730 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
04/05/2012US20120082729 Quick dissolve compositions and tablets based thereon
04/05/2012US20120082725 Composition Comprising Immunogenic Microparticles
04/05/2012US20120082720 Compositions For Treating Chronic Viral Infections
04/05/2012US20120082719 Compositions For Treating Chronic Viral Infections
04/05/2012US20120082717 Complex, multilayer using the same, and device coated with the multilayer
04/05/2012US20120082716 Cytotoxic agents
04/05/2012US20120082713 Photochrome- or near ir dye-coupled polymeric matrices for medical articles
04/05/2012US20120082706 Medical device for drug delivery
04/05/2012US20120082700 Compositions for stimulation of mammalian innate immune resistance to pathogens
1 ... 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 ... 1798